Summary
The main objective of cell bioengineering is to generate customized tissues that allow recovering the lost functions in the organism in the absence of immune rejection. Although the possibility of in vitro generation of entire organs is technically very complex, obtaining specific cell types for replacement therapies seems to be a more realistic goal at mean time. In this context, those pathologies affected by the dysfunction of a specific cell type, as it is the case of β-cell in diabetes, would be in principle candidates to benefit from cell transplantation protocols. Embryonic stem cells offer interesting possibilities in this context because they fulfill two important criteria: (i) High proliferation rate by symmetric cell division, overcoming the problem of biomass scarcity and (ii) Plasticity of differentiating to all cell types present in the adult organism, including the germ line. Different approaches have been developed in vitro to obtain insulin-producing cells from embryonic stem cells. Nevertheless, a definitive protocol does not exist yet. However, the experience accumulated in this field by the different laboratories has provided considering key points that would help to design a preferred protocol in the future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
DeFronzo, R. A., Ferrannini, E., Keen, H., and Zimmet, P. (eds.) (2004). International Textbook of Diabetes Mellitus. John Wiley and Sons, Chichester, UK.
Prentki, M., Joly, E., El-Assaad, W., and Roduit, R. (2002) Malonyl-CoA signalling, lipid partitioning, and glucolipotoxicity. Role in β-cell adaptation and failure in the etiology of diabetes. Diabetes 51 (Suppl 3), S405–S413.
Shapiro, A. M. J., Lakey, J. R. T., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., and Rajotte, R. V. (2000). Islet transplantation in seven patients with type 1 diabetes mellitus using a corticoid-free immunosuppressive regime. N. Engl. J. Med. 343: 230–238.
Ryan, E. A., Paty, B. W., Senior, P. A., Bigam, D., Alfadhli, E., Kneteman, N. M., Lakey, J. R., and Shapiro, A. M. (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54, 2060–2069.
Roche, E., Reig, J. A., Campos, A., Paredes, B., Isaac, J. R., Lim, S., Calne, R. Y., and Soria, B. (2005) Insulin-secreting cells derived from stem cells: clinical perspectives, hypes and hopes. Transplant. Immunol. 15: 113–129.
Roche, E., Santana, A., Vicente-Salar, N., and Reig, J. A. (2005) From stem cells to insulin-producing cells: towards a bioartificial endocrine pancreas. Panminerva Medica 47, 39–51.
Roche, E., Sepulcre, M. P., Enseñat-Waser, R., Maestre, I., Reig, J. A., and Soria, B. (2003) Bio-engineering insulin-secreting cells from embryonic stem cells: a review of progress. Med. Biol. Eng. Comp. 41, 384–391.
Soria, B., Skoudy, A., and Martín, F. (2001) From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia 44: 407–415.
Soria, B., Roche, E., Berna, G., León-Quinto, T., Reig, J. A., and Martín, F. (2000) Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49: 157–162.
Vaca, P., Martin, F., Vegara-Meseguer, J. M., Rovira, J. M., Berna, G., and Soria, B. (2006) Induction of differentiation of embryonic stem cells into insulin secreting cells by foetal soluble factors. Stem Cells 24, 258–265.
Leon-Quinto, T., Jones, J., Skoudy A., Burcin, M., Soria, B. (2004) In vitro directed differentiation of mouse embryonic ítem cells into insulin-producing cells. Diabetologia 47: 1442–1451.
Lumelsky, N., Blondel, O., Laeng, P., Velasco, I., Ravin, R., and McKay, R. (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292: 1389–1394.
Hori, Y., Rulifson, I. C., Tsai, B. C., Heit, J. J., Cahoy, J. D., and Kim, S. K. (2002) Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 99: 16105–16110.
Moritoh, Y., Yamato, E., Yasui, Y., Miyazaki, S., and Miyazaki, J. (2003) Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells. Diabetes 52: 1163–1168.
Blyszczuk, P., Czyz, J., Kania, G., Wagner, M., Roll, U., St-Onge, L., and Wobus, A. (2003) Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc. Natl. Acad. Sci. U.S.A. 100, 998–1003.
Roche, E., Sepulcre, P., Reig, J. A., Santana, A., and Soria, B. (2005) Ectodermal commitment of insulin-producing cells derived from mouse embryonic stem cells. FASEB J. 19, 1341–1343.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press
About this protocol
Cite this protocol
Roche, E., Ensenat-Waser, R., Vicente-Salar, N., Santana, A., Zenke, M., Reig, J.A. (2007). Insulin-Producing Cells from Embryonic Stem Cells Experimental Considerations. In: Vemuri, M.C. (eds) Stem Cell Assays. Methods in Molecular Biology™, vol 407. Humana Press. https://doi.org/10.1007/978-1-59745-536-7_20
Download citation
DOI: https://doi.org/10.1007/978-1-59745-536-7_20
Publisher Name: Humana Press
Print ISBN: 978-1-58829-744-0
Online ISBN: 978-1-59745-536-7
eBook Packages: Springer Protocols